Affiliation:
1. Centre de Recherche en Infectiologie de l’Université Laval, Centre Hospitalier Universitaire de Québec (Pavillon CHUL)
2. Division de Microbiologie, Faculté de Médecine, Université Laval, Sainte-Foy, Québec, Canada
Abstract
ABSTRACT
Clostridium difficile
is the major causative agent of nosocomial antibiotic-associated diarrhea, colitis, and pseudomembranous colitis. The pathogenicity of
C. difficile
is closely related to the production of toxins A and B. Toxigenic
C. difficile
detection by a tissue culture cytotoxin assay is often considered the “gold standard.” However, this assay is time consuming, as it implies an incubation period of at least 24 h. We have developed a rapid real-time fluorescence-based multiplex PCR assay targeting the
C. difficile
toxin genes
tcdA
and
tcdB
, with the Smart Cycler. Two molecular beacons bearing different fluorophores were used as internal probes specific for each amplicon type. The analytical sensitivity of the assay was around 10 genome copies for all nine
C. difficile
strains tested, representing the 6 most common toxinotypes. The specificity was demonstrated by the absence of amplification with DNA purified from bacterial species other than
C. difficile
(
n
= 14), including
Clostridium sordellii
for which the lethal toxin gene sequence is closely related to the toxin genes of
C. difficile
. Following a rapid (15 min) and simple fecal sample preparation protocol, both
tcdA
and
tcdB
were efficiently amplified from 28 of 29 cytotoxin-positive feces samples. There was no amplification observed with all 27 cytotoxin-negative feces samples tested. This is the first real-time PCR assay for the detection of
C. difficile
. It is rapid, sensitive, and specific and allows detection of
C. difficile
directly from feces samples.
Publisher
American Society for Microbiology
Reference37 articles.
1. Alfa, M. J., B. Swan, P. VanDekerkhove, P. Pang, and G. K. M. Harding. 2002. The diagnosis of Clostridium difficile-associated diarrhea: comparison of triage C. difficile panel, EIA for Tox A/B and cytotoxin assays. Diagn. Microbiol. Infect. Dis.43:257-263.
2. Allen S. D. C. L. Emery and J. A. Siders. 1999. Clostridium p. 654-671. In P. R. Murray E. J. Baron M. A. Pfaller F. C. Tenover and R. H. Yolken (ed.) Manual of clinical microbiology 7th ed. American Society for Microbiology Washington D.C.
3. Arzese, A., G. Trani, L. Riul, and G. A. Botta. 1995. Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile.Eur. J. Clin. Microbiol. Infect. Dis.14:716-719.
4. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea
5. Bartlett J. G. 1990. Clostridium difficile : Clinical considerations. Rev. Infect. Dis. 12 (Suppl. 2) : S243-S251.
Cited by
180 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献